Prothena (PRTA) News Today $8.18 +0.12 (+1.43%) As of 10:51 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Goldman Sachs Group Inc. Decreases Position in Prothena Corporation plc $PRTASeptember 16 at 4:11 AM | marketbeat.comWhat is Zacks Research's Estimate for Prothena Q1 Earnings?September 16 at 2:55 AM | marketbeat.comQ1 Earnings Forecast for Prothena Issued By Zacks ResearchSeptember 16 at 2:09 AM | americanbankingnews.comSiren L.L.C. Grows Stock Holdings in Prothena Corporation plc $PRTASeptember 13, 2025 | marketbeat.comAnalysts Set Prothena Corporation plc (NASDAQ:PRTA) Price Target at $19.75September 11, 2025 | americanbankingnews.comProthena Corporation plc (NASDAQ:PRTA) Receives Consensus Recommendation of "Hold" from BrokeragesSeptember 9, 2025 | marketbeat.comRafferty Asset Management LLC Decreases Stake in Prothena Corporation plc $PRTASeptember 5, 2025 | marketbeat.comJMP Securities Lowers Prothena (NASDAQ:PRTA) Price Target to $11.00September 4, 2025 | marketbeat.comProthena Corporation plc $PRTA Stake Lowered by Palo Alto Investors LPSeptember 4, 2025 | marketbeat.comArmistice Capital LLC Sells 40,000 Shares of Prothena Corporation plc $PRTASeptember 2, 2025 | marketbeat.comNuveen LLC Acquires Shares of 149,961 Prothena Corporation plc $PRTASeptember 1, 2025 | marketbeat.comSiren L.L.C. Raises Stake in Prothena Corporation plc $PRTAAugust 31, 2025 | marketbeat.comPiper Sandler Has Lowered Expectations for Prothena (NASDAQ:PRTA) Stock PriceAugust 30, 2025 | marketbeat.comProthena's (PRTA) Buy Rating Reiterated at Chardan CapitalAugust 30, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Decreases Holdings in Prothena Corporation plc $PRTAAugust 30, 2025 | marketbeat.comProthena Corporation plc: Prothena to Participate in the Cantor Fitzgerald Global Healthcare ConferenceAugust 28, 2025 | finanznachrichten.deProthena to Participate in the Cantor Fitzgerald Global Healthcare ConferenceAugust 28, 2025 | businesswire.comProthena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical ProgramAugust 27, 2025 | businesswire.comWellington Management Group LLP Acquires 68,652 Shares of Prothena Corporation plc $PRTAAugust 25, 2025 | marketbeat.comProthena (NASDAQ:PRTA) Stock Passes Below 200 Day Moving Average - Time to Sell?August 24, 2025 | marketbeat.comProthena Corporation plc (NASDAQ:PRTA) Receives Consensus Recommendation of "Hold" from AnalystsAugust 15, 2025 | marketbeat.comProthena (NASDAQ:PRTA) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?August 14, 2025 | marketbeat.comCitizens JMP Remains a Buy on Prothena (PRTA)August 9, 2025 | theglobeandmail.comFY2026 EPS Estimates for Prothena Lifted by Chardan CapitalAugust 9, 2025 | marketbeat.comCantor Fitzgerald Increases Earnings Estimates for ProthenaAugust 8, 2025 | marketbeat.comFY2025 EPS Estimates for Prothena Reduced by HC WainwrightAugust 8, 2025 | marketbeat.comNovo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns HopefulAugust 7, 2025 | msn.comProthena (NASDAQ:PRTA) Price Target Cut to $10.00 by Analysts at Royal Bank Of CanadaAugust 6, 2025 | marketbeat.comProthena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with CardiomyopathyAugust 6, 2025 | businesswire.comProthena's (PRTA) Buy Rating Reiterated at HC WainwrightAugust 6, 2025 | marketbeat.comProthena (NASDAQ:PRTA) Given "Buy" Rating at Chardan CapitalAugust 6, 2025 | marketbeat.comProthena (NASDAQ:PRTA) Announces Earnings Results, Misses Expectations By $0.80 EPSAugust 5, 2025 | marketbeat.com9 Analysts Assess Prothena Corp: What You Need To KnowAugust 5, 2025 | benzinga.comProthena Reports Q2 2025 Financial Results and Pipeline ProgressAugust 4, 2025 | tipranks.comProthena Reports Second Quarter 2025 Financial Results and Business HighlightsAugust 4, 2025 | businesswire.comProthena Corporation plc (NASDAQ:PRTA) Shares Purchased by DCF Advisers LLCAugust 4, 2025 | marketbeat.comFederated Hermes Inc. Sells 199,922 Shares of Prothena Corporation plc (NASDAQ:PRTA)August 3, 2025 | marketbeat.comA Glimpse of Prothena Corp's Earnings PotentialAugust 2, 2025 | benzinga.comProthena Secures Leadership with New Executive AgreementsJuly 31, 2025 | msn.comProthena (PRTA) Projected to Post Earnings on MondayJuly 30, 2025 | marketbeat.comProthena to Report Second Quarter 2025 Financial Results on August 4July 28, 2025 | finance.yahoo.comProthena (NASDAQ:PRTA) Stock Price Passes Below Two Hundred Day Moving Average - Time to Sell?July 12, 2025 | marketbeat.comProthena (NASDAQ:PRTA) Stock Price Passes Below 200 Day Moving Average - Should You Sell?July 4, 2025 | marketbeat.comProthena Corporation plc (NASDAQ:PRTA) Given Consensus Rating of "Hold" by AnalystsJune 25, 2025 | marketbeat.comProthena Corp (PRTA) Receives Reiterated Neutral Rating from Cantor Fitzgerald | PRTA Stock NewsJune 20, 2025 | gurufocus.comCantor Fitzgerald Reiterates "Neutral" Rating for Prothena (NASDAQ:PRTA)June 20, 2025 | marketbeat.comRoche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA)June 19, 2025 | finance.yahoo.comProthena Announces Corporate RestructuringJune 18, 2025 | finance.yahoo.comProthena (NASDAQ:PRTA) Shares Pass Below 200 Day Moving Average - Time to Sell?June 18, 2025 | marketbeat.comRoche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA)June 17, 2025 | msn.com Get Prothena News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRTA Media Mentions By Week PRTA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTA News Sentiment▼0.850.63▲Average Medical News Sentiment PRTA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTA Articles This Week▼125▲PRTA Articles Average Week Get the Latest News and Ratings for PRTA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Prothena and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Apogee Therapeutics News Today Sarepta Therapeutics News Today Aurinia Pharmaceuticals News Today Cidara Therapeutics News Today Vericel News Today Phibro Animal Health News Today Ardelyx News Today Twist Bioscience News Today Vera Therapeutics News Today Edgewise Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTA) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prothena Corporation plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Prothena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTA Stock Alerts